None listed
Conditions
Interventions
Others(dietary education) : There is no difference between the intervention groups as an appropriate dietary recommendation and education will be performed for all subjects.
Sponsors
The Catholic University of Korea, Seoul St. Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? Patients who underwent gastrectomy (including both total gastrectomy and subtotal gastrectomy) for gastric cancer ? Perform gastrectomy within 12 months from the time of study participation, more than 3 months ? Patients with abdominal pain or discomfort recurring at least 3 days per month in the past 3 months
Exclusion criteria
Exclusion criteria: ? Subjects who cannot use a smartphone ? If the skin is sensitive or has an allergic reaction ? Subjects who have received chemotherapy ? Subjects with a current or past history of inflammatory bowel disease (Crohn's disease or ulcerative proctitis), celiac disease, carcinoid syndrome, hereditary inheritance or intestinal obstruction ? If you have undergone gastrointestinal surgery other than gastrectomy (however, you can register for appendectomy, cholecystectomy and hernia surgery) ? Subjects whose mastication function has been lost ? Subjects with major psychiatric disorders (DSM-III or DSM-IV) that cannot be controlled by antidepressant drug therapy (however, those with mental illness are excluded regardless of current drug therapy) ? Subjects with a history of drug or alcohol abuse (within 12 months prior to screening) ? Subjects who have participated in drug or medical device research within 30 days prior to participation in the clinical trial ? Pregnant or lactating women (in the case of women of childbearing age, the urine pregnancy test result within 14 days prior to administration of the test drug must be negative, and registration is possible only when consenting to use an appropriate contraceptive method to prevent pregnancy) ? Subjects with chronically poor oral intake or persistent parenteral subjects, subjects with poor systemic conditions. However, temporary poor oral intake due to current disease is excluded. ? People with unstable systemic disease (active infection, serious cardiovascular disease [including myocardial infarction within 1 year], severe renal failure (Creatinine> 2.0 mg/dL), severe liver disease or metabolic disease, metabolic dysfunction (diabetes Etc.), except when factors prohibiting the use of clinical trial drugs are found in the results of physical examinations or clinical or diagnostic medical tests, or that may affect the interpretation of the results or cause the subject to be at risk due to complications of treatment. ? Subjects judged to be inappropriate according to the judgment of other examiners
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of dumping syndrome and efficacy of dietary education | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy of continuous glucose monitoring and relation of hypoglycemia and GI symptoms | — |
Countries
Korea, Republic of
Contacts
Public ContactDonghoon Kang
The Catholic University of Korea, Seoul St. Mary's Hospital
Outcome results
None listed